“…In the following study, Remko et al [172] used ab initio methods to study molecular structure, lipophilicity, solubility, absorption, and blood-brain barrier penetration of some novel antiangiogenic agents (semaxanib, sunitinib, N-methylsunitinib, sorafenib, motesanib, ABT-869, vatalanib, vandetanib, AEE 788, CP-547632, A-1, A-2, A-3, and A-4). The results show that, whenever possible, the most stable conformers are stabilized by intramolecular hydrogen bonds.…”